15d
MedPage Today on MSNProposed Legislation Targets Breaking Up NIAIDThe proposed legislation was introduced in the House and referred to the House Committee on Energy and Commerce at the end of last week. "For us, on the scientific and clinical si ...
A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) ...
The move, which will take effect in December, will see Fauci leave his positions as director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief of the NIAID Laboratory of ...
Reports of TB date back to the time of Hippocrates, but the Kansas outbreak shows that the ancient disease is very much a ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
In July 2018, the National Institute of Allergy and Infectious Diseases (NIAID) at NIH announced that it would co-fund a major study to evaluate a type of stem cell as treatment for moderate to severe ...
When the Morbidity and Mortality Weekly Report landed on Dr. Anthony Fauci’s desk in June 1981, he had no idea it would be ...
The study suggests that omalizumab could become a safer, more effective alternative to OIT for people with highly sensitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results